125 related articles for article (PubMed ID: 9192246)
1. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
Sakata Y; Kodama K; Ishikura F; Komamura K; Hasegawa S; Sakata Y; Hirayama A
Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
[TBL] [Abstract][Full Text] [Related]
2. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction.
Sakata Y; Kodama K; Komamura K; Lim YJ; Ishikura F; Hirayama A; Kitakaze M; Masuyama T; Hori M
Am Heart J; 1997 Jun; 133(6):616-21. PubMed ID: 9200388
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction.
Kobayashi Y; Goto Y; Daikoku S; Itoh A; Miyazaki S; Ohshima S; Nonogi H; Haze K
Jpn Circ J; 1998 Mar; 62(3):183-9. PubMed ID: 9583444
[TBL] [Abstract][Full Text] [Related]
4. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
Ito H; Taniyama Y; Iwakura K; Nishikawa N; Masuyama T; Kuzuya T; Hori M; Higashino Y; Fujii K; Minamino T
J Am Coll Cardiol; 1999 Mar; 33(3):654-60. PubMed ID: 10080465
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention.
Gao MD; Zhang EY; Liu YY; Li XW; Xiao JY; Sun GY; Liu Y
Chin Med J (Engl); 2020 Apr; 133(7):766-772. PubMed ID: 32149760
[TBL] [Abstract][Full Text] [Related]
6. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
7. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.
Tsubokawa A; Ueda K; Sakamoto H; Iwase T; Tamaki S
Circ J; 2002 Dec; 66(12):1119-23. PubMed ID: 12499617
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel.
Zhao JL; Yang YJ; Chen JL; Kang LM; Wu Y; Gao RL
Clin Chim Acta; 2006 Dec; 374(1-2):100-5. PubMed ID: 16824503
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.
Ikeda N; Yasu T; Kubo N; Hashimoto S; Tsuruya Y; Fujii M; Kawakami M; Saito M
Heart; 2004 Feb; 90(2):181-5. PubMed ID: 14729792
[TBL] [Abstract][Full Text] [Related]
10. No reflow phenomenon in coronary heart disease.
Ito H
J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
[TBL] [Abstract][Full Text] [Related]
11. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
12. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
[TBL] [Abstract][Full Text] [Related]
13. The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatment options.
Kaul S
J Cardiol; 2014 Aug; 64(2):77-85. PubMed ID: 24799155
[TBL] [Abstract][Full Text] [Related]
14. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Auchampach JA; Gross GJ
Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP).
Minamino T; Jiyoong K; Asakura M; Shintani Y; Asanuma H; Kitakaze M;
Circ J; 2004 Feb; 68(2):101-6. PubMed ID: 14745142
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil improves ischemic changes in epicardial ECG during short-term coronary occlusion by opening ATP-sensitive potassium channels in pigs.
Takaoka A; Nakae I; Liu Q; Yamamoto K; Ito M; Kinoshita M
Cardiovasc Drugs Ther; 1997 Dec; 11(6):757-66. PubMed ID: 9512871
[TBL] [Abstract][Full Text] [Related]
18. K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.
Genda S; Miura T; Miki T; Ichikawa Y; Shimamoto K
J Am Coll Cardiol; 2002 Oct; 40(7):1339-46. PubMed ID: 12383584
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
[TBL] [Abstract][Full Text] [Related]
20. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis.
Iwakura K; Ito H; Okamura A; Koyama Y; Date M; Higuchi Y; Inoue K; Kimura R; Nagai H; Imai M; Toyoshima Y; Ozawa M; Ito N; Okazaki Y; Shibuya M; Suenaga H; Kubota A; Fujii K
Circ J; 2009 May; 73(5):925-31. PubMed ID: 19325192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
